Royce & Associates’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.1K Buy
+14,720
New +$74.1K ﹤0.01% 770
2025
Q2
Sell
-577,703
Closed -$4.39M 818
2025
Q1
$4.39M Sell
577,703
-301,924
-34% -$2.52M 0.05% 467
2024
Q4
$8.46M Sell
879,627
-93,226
-10% -$726K 0.08% 370
2024
Q3
$5.75M Buy
972,853
+48,539
+5% +$322K 0.05% 446
2024
Q2
$6.41M Buy
924,314
+27,698
+3% +$195K 0.06% 429
2024
Q1
$6.9M Buy
896,616
+34,122
+4% +$274K 0.06% 429
2023
Q4
$7.56M Sell
862,494
-5,500
-0.6% -$40.3K 0.07% 399
2023
Q3
$6.33M Sell
867,994
-7,706
-0.9% -$57.4K 0.06% 423
2023
Q2
$5.79M Buy
875,700
+33,700
+4% +$172K 0.06% 466
2023
Q1
$2.87M Buy
842,000
+147,000
+21% +$569K 0.03% 607
2022
Q4
$1.93M Buy
695,000
+150,000
+28% +$448K 0.02% 652
2022
Q3
$1.56M Buy
+545,000
New +$1.94M 0.02% 663
2018
Q4
Sell
-4,336
Closed -$27K 1182
2018
Q3
$27K Buy
4,336
+2,035
+88% +$9.2K ﹤0.01% 1119
2018
Q2
$15K Buy
2,301
+1,230
+115% +$8.76K ﹤0.01% 1176
2018
Q1
$7K Buy
+1,071
New +$12.5K ﹤0.01% 1224

Other funds holding MDXG

Royce & Associates's MDXG Position: Q1 2026 in Review

Royce & Associates opened a new position in MiMedx Group (MDXG) in Q1 2026: 14,720 shares worth $58.1K. The stake represents ﹤0.01% of the portfolio and ranks #770 among its holdings. This is a return to the name: Royce & Associates previously reported a position in MDXG as recently as Q1 2025.

Royce & Associates first reported a position in MDXG in Q1 2018 and has held it in 15 quarters since. The position peaked at $8.46M in Q4 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Royce & Associates held 14,720 shares of MiMedx Group worth $58.1K as of Q1 2026.
  • MiMedx Group was a new Royce & Associates position in Q1 2026.
  • MiMedx Group made up ﹤0.01% of Royce & Associates's portfolio in Q1 2026, its #770 holding.
  • Royce & Associates first reported a position in MiMedx Group in Q1 2018 and has held it in 15 quarters since.
  • Royce & Associates's MiMedx Group position peaked at $8.46M in Q4 2024.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.